Patient ownership and control of personal data and increased regulatory compliance are key areas of improvement in clinical trials. Blockchain is a form of Distributed Ledger Technology (DLT) that supports trust, immutability of transactions and prevents single point of failure.
Blockchain technology involves the implementation of Decentralised Identifiers (DID), ‘virtual’ wallets, Verifiable Credentials (VC), smart contracts, and a blockchain layer to record transactions between parties during the clinical trial Informed Consent process. Blockchain technology puts patients in control of their identity and their data and has the potential to significantly change how patients are enrolled and participate in clinical trials. Further, blockchain technology puts sponsors in control of the Informed Consent process and documentation and has the potential to increase speed and compliance through ‘anytime’, real-time auditing.
During this webinar we will present our work as part of a multi-pharma proof-of-concept (PoC) led by Pistoia Alliance, to develop and implement a solution based on blockchain technology which will provide patients with the simplest possible system to participate in a clinical trial and sponsors with an audit trail of all the transactions between relevant stakeholders in the Clinical Trial Informed Consent process.